Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Qiang-Wei Wang
A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
Frontiers in Genetics
Genetics
Molecular Medicine
Related publications
Prognostic Value of MGMT Promoter Methylation in Glioblastoma Patients Treated With Temozolomide-Based Chemoradiation: A Portuguese Multicentre Study
Oncology Reports
Medicine
Cancer Research
Oncology
18f-FDG-Pet-Based Radiomics Signature Predicts MGMT Promoter Methylation Status in Primary Diffuse Glioma
Cancer Imaging
Nuclear Medicine
Radiology
Ultrasound Technology
Oncology
Radiological
Imaging
Medicine
Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas
ISRN Neurology
A Novel Prognostic Six-CpG Signature in Glioblastomas
CNS Neuroscience and Therapeutics
Psychiatry
Mental Health
Physiology
Pharmacology
Identification of a DNA Methylation Signature to Predict Disease-Free Survival in Locally Advanced Rectal Cancer
Oncotarget
Oncology
MGMT Promoter Methylation Cutoff With Safety Margin for Selecting Glioblastoma Patients Into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.
Clinical Cancer Research
Cancer Research
Oncology
Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status
OncoTargets and Therapy
Oncology
Pharmacology
A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Where Does O6 -Methylguanine DNA Methyltransferase Promoter Methylation Assessment Place Temozolomide in the Future Standards of Care for Glioblastoma?
Cancer
Cancer Research
Oncology
